Cargando…

Diffusion-weighted imaging–fluid-attenuated inversion recovery mismatch is associated with better neurologic response to intravenous thrombolytic therapy in acute ischemic stroke patients

OBJECTIVE: To investigate differences in the effect of intravenous (IV) thrombolysis regarding the mismatch of diffusion-weighted imaging–fluid-attenuated inversion recovery (DWI-FLAIR) among acute ischemic stroke patients who visited the emergency department (ED) within 3 hours from the onset of sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Jong Yeong, Han, Sang Kuk, Shin, Dong Hyuk, Na, Ji Ung, Lee, Hyun Jung, Choi, Pil Cho, Lee, Jeong Hun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Emergency Medicine 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052849/ https://www.ncbi.nlm.nih.gov/pubmed/27752570 http://dx.doi.org/10.15441/ceem.14.043

Ejemplares similares

Intravenous Thrombolytics in the Treatment of Acute Ischemic Stroke
por: Alhadid, Kenda, et al.
Publicado: (2023)

Clinical-CT mismatch defined NIHSS ≥ 8 and CT-ASPECTS ≥ 9 as a reliable marker of candidacy for intravenous thrombolytic therapy in acute ischemic stroke
por: Wu, Hung-Ming, et al.
Publicado: (2021)

Safety and feasibility of intravenous thrombolytic therapy in Iranian patients with acute ischemic stroke
por: Mehrpour, Masoud, et al.
Publicado: (2013)

Intravenous Thrombolytic Treatment in the Oldest Old
por: García-Caldentey, Juan, et al.
Publicado: (2012)

Retrosternal mass: An interesting allergic reaction to intravenous thrombolytic therapy for acute ischemic stroke
por: Mehrpour, Masoud, et al.
Publicado: (2013)

Predictive Factors for Functional Outcomes After Intravenous Thrombolytic Therapy in Acute Ischemic Stroke
por: Çetiner, Mustafa, et al.
Publicado: (2018)

Intravenous thrombolytic therapy in acute ischemic stroke: The art and science of treatment decision making
por: Sylaja, P. N., et al.
Publicado: (2008)

Retrospective Evaluation of the Results of Low-Dose Intravenous Thrombolytic Therapy in Acute Ischemic Stroke
por: Cetiner, Mustafa, et al.
Publicado: (2023)

Eligibility Assessment for Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients; Evaluating Barriers for Implementation
por: Ayromlou, Hormoz, et al.
Publicado: (2014)

Arterial Obstruction on Computed Tomographic or Magnetic Resonance Angiography and Response to Intravenous Thrombolytics in Ischemic Stroke
por: Mair, Grant, et al.
Publicado: (2017)

Renal Dysfunction and In‐Hospital Outcomes in Patients With Acute Ischemic Stroke After Intravenous Thrombolytic Therapy
por: Rao, Zhen‐Zhen, et al.
Publicado: (2019)

Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative
por: Sasanejad, Payam, et al.
Publicado: (2021)

Thrombolytic Dilemma: A Case Report of Early Puerperium Ischemic Stroke Treated With Intravenous Thrombolysis
por: Santos, André, et al.
Publicado: (2023)

Effect of Intravenous Thrombolytic Dose of Alteplase on Long-Term Prognosis in Patients with Acute Ischemic Stroke
por: Zhai, Mingfeng, et al.
Publicado: (2023)

Intravenous thrombolytic therapy for acute ischemic stroke in Hubei, China: a survey of thrombolysis rate and barriers
por: Zhou, Yanfeng, et al.
Publicado: (2019)

Efficacy of Rosuvastatin Combined with rt-PA Intravenous Thrombolytic Therapy for Elderly Acute Ischemic Stroke Patients
por: Zhu, Jianzhong, et al.
Publicado: (2022)

Predictive role of pre-thrombolytic hs-CRP on the safety and efficacy of intravenous thrombolysis in acute ischemic stroke
por: Cheng, Xu-Dong, et al.
Publicado: (2023)

Immediate outcome prognostic value of plasma factors in patients with acute ischemic stroke after intravenous thrombolytic treatment
por: Lu, Huanhuan, et al.
Publicado: (2022)

The effects of the coronavirus disease pandemic on intravenous thrombolytic therapy among patients with acute ischemic stroke in Dalian, China
por: Pan, Xin, et al.
Publicado: (2023)

Retracted: Efficacy of Rosuvastatin Combined with rt-PA Intravenous Thrombolytic Therapy for Elderly Acute Ischemic Stroke Patients
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Tenecteplase vs. Alteplase for Intravenous Thrombolytic Therapy of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
por: Shen, Ziyi, et al.
Publicado: (2023)

Hematologic parameters to predict negative cerebrospinal fluid examination results among neurologically intact patients who underwent lumbar puncture on suspicion of central nervous system infection
por: Kim, Ji Hwan, et al.
Publicado: (2017)

Repeated Thrombolytic Therapy in Patients with Recurrent Acute Ischemic Stroke
por: Yoo, Han Soo, et al.
Publicado: (2013)

Comparison of the GlideRite to the conventional malleable stylet for endotracheal intubation by the Macintosh laryngoscope: a simulation study using manikins
por: Kong, Yong Tack, et al.
Publicado: (2016)

Early and intermediate prognosis of intravenous thrombolytic therapy in acute ischemic stroke subtypes according to the causative classification of stroke system
por: Pashapour, Ali, et al.
Publicado: (2013)

Mean Platelet Volume, C-Reactive Protein, and Prognosis in Patients with Acute Ischemic Stroke Following Intravenous Thrombolytic Treatment
por: İnanç, Yusuf, et al.
Publicado: (2018)

Individualized intravenous thrombolytic strategy for acute ischemic stroke with large vessel occlusion on the era of mechanical thrombectomy: cases report
por: Xing, Pengfei, et al.
Publicado: (2019)

Evolution of the Thrombolytic Treatment Window for Acute Ischemic Stroke
por: Stemer, Andrew, et al.
Publicado: (2010)

Perfusion-diffusion Mismatch Predicts Early Neurological Deterioration in Anterior Circulation Infarction without Thrombolysis
por: Hsu, Chia-Yu, et al.
Publicado: (2015)

Characteristics of blood tests in patients with acute cerebral infarction who developed symptomatic intracranial hemorrhage after intravenous administration of recombinant tissue plasminogen activator
por: Lee, Chungjo, et al.
Publicado: (2019)

Acute Thrombolytic Therapy Combined with the Green Channel Can Reduce the Thrombolytic Time and Improve Neurological Function in Acute Stroke Patients
por: Hong, Zhen, et al.
Publicado: (2022)

Identifying Gaps and Missed Opportunities for Intravenous Thrombolytic Treatment of Inpatient Stroke
por: Topiwala, Karan, et al.
Publicado: (2020)

T2-fluid attenuated inversion recovery mismatch in tumefactive multiple sclerosis
por: Le, Duc, et al.
Publicado: (2023)

Thrombolytic or endovascular therapy for acute ischemic stroke: Time is brain
por: Mijajlovic, Milija D.
Publicado: (2014)

Susceptibility-weighted Imaging in Thrombolytic Therapy of Acute Ischemic Stroke
por: Li, Lin, et al.
Publicado: (2017)

Cholesterol reducer and thrombolytic therapy in acute ischemic stroke patients
por: Poupore, Nicolas, et al.
Publicado: (2020)

Retracted: Acute Thrombolytic Therapy Combined with the Green Channel Can Reduce the Thrombolytic Time and Improve Neurological Function in Acute Stroke Patients
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Prognostic Value of Diffusion-Weighted Imaging (DWI) Apparent Diffusion Coefficient (ADC) in Patients with Hyperacute Cerebral Infarction Receiving rt-PA Intravenous Thrombolytic Therapy
por: Sui, Hai-Jing, et al.
Publicado: (2016)

The Usefulness of the Kurashiki Prehospital Stroke Scale in Identifying Thrombolytic Candidates in Acute Ischemic Stroke
por: Jang, Jieun, et al.
Publicado: (2014)

The potential role of insulin resistance in predicting outcome from intravenous thrombolytic therapy
por: Ali, Mona, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b5f33js4ln1fdbagjcf5t46f25